Evogene Ltd. (EVGN)
0.8106
-0.01
(-1.16%)
USD |
NASDAQ |
Apr 10, 16:00
0.7956
-0.02
(-1.85%)
After-Hours: 20:00
Evogene EPS Diluted (Quarterly) : -0.609 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| MediWound Ltd. | -0.5601 |
| Compugen Ltd. | 0.6002 |
| Pluri, Inc. | -0.7066 |
| BioLineRx Ltd. | -0.32 |
| XTL Biopharmaceuticals Ltd. | -0.1169 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.338M |
| Revenue (Quarterly) | 0.314M |
| Total Expenses (Quarterly) | 5.607M |
| Enterprise Value | 9.287M |
| Gross Profit Margin (Quarterly) | -16.88% |
| Profit Margin (Quarterly) | -1.70K% |
| Earnings Yield | -143.4% |
| Normalized Earnings Yield | -143.42 |